It has been demonstrated that PBMT reverses cognitive deficits in Alzheimer’s disease (AD) by promoting neurogenesis through the stimulation of the expression of interferon γ/interleukin 10 (IFN-γ/IL-10) in T lymphocytes24. The gene discussed is IL10; the disease is early-onset autosomal dominant Alzheimer disease.